The JSE could benefit on Tuesday from continued optimism Covid-19 has peaked, with Asian markets firmly up on news of another possible vaccine.
US biotech firm Novavax has said it is starting human trials for its vaccine, while Japan has moved to lift lockdown restrictions, while also providing hefty stimulus...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.